Literature DB >> 8547139

Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain.

C Pastore1, A Gloghini, G Volpe, J Nomdedeu, E Leonardo, U Mazza, G Saglio, A Carbone, G Gaidano.   

Abstract

In this study we have tested the distribution of Kaposi's sarcoma herpesvirus (KSHV) DNA sequences throughout the spectrum of lymphoid neoplasia in Italy and Spain. 180 cases of lymphoid malignancies representative of the major histologic and immunophenotypic categories of B- and T-cell tumours were analysed by means of a polymerase chain reaction-based assay. KSHV sequences were consistently absent in all categories of lymphoid malignancies studied, with the exception of a subset of B-cell non-Hodgkin's lymphomas localizing in the pleural, pericardial or peritoneal cavities, and fulfilling the diagnostic criteria of body-cavity-based lymphoma. The selective and consistent association of KSHV sequences with cases of body-cavity-based lymphoma throughout the spectrum of lymphoid neoplasms suggests that KSHV may be involved in the pathogenesis of this peculiar type of lymphoid malignancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547139     DOI: 10.1111/j.1365-2141.1995.tb05410.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.

Authors:  G Gaidano; E Castaños-Velez; P Biberfeld
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

Review 2.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus.

Authors:  B Damania; M DeMaria; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  AIDS and non AIDS-related malignant lymphoma in Tanzania.

Authors:  Ephata E Kaaya; Esmeralda Castaños-Velez; Marianne Ekman; Amos Mwakigonja; Primo Carneiro; Leonard Lema; James Kitinya; Anika Linde; Peter Biberfeld
Journal:  Afr Health Sci       Date:  2006-06       Impact factor: 0.927

6.  Transcription program of murine gammaherpesvirus 68.

Authors:  DeeAnn Martinez-Guzman; Tammy Rickabaugh; Ting-Ting Wu; Helen Brown; Steven Cole; Moon Jung Song; Leming Tong; Ren Sun
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiheng He; Yunhua Liu; Deguang Liang; Zhuo Wang; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

Review 8.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function.

Authors:  Fei Yuan; Zeng-Qiang Gao; Vladimir Majerciak; Lei Bai; Meng-Lu Hu; Xiao-Xi Lin; Zhi-Ming Zheng; Yu-Hui Dong; Ke Lan
Journal:  PLoS Pathog       Date:  2018-08-10       Impact factor: 6.823

10.  Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate.

Authors:  H Hjalgrim; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.